Vician et al., 1976 - Google Patents
Purification of human blood clotting factor X by blue dextran agarose affinity chromatographyVician et al., 1976
- Document ID
- 8349760933721504943
- Author
- Vician L
- Tishkoff G
- Publication year
- Publication venue
- Biochimica et Biophysica Acta (BBA)-Protein Structure
External Links
Snippet
Blue Dextran 2000 coupled covalently to agarose has been used as an affinity column for the rapid separation of human blood clotting Factor X, Factor X has been isolated with approximately 2000-fold purification from human citrated plasma and shows single …
- 229940012426 factor X 0 title abstract description 38
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21022—Coagulation factor IXa (3.4.21.22)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/814—Enzyme separation or purification
- Y10S435/815—Enzyme separation or purification by sorption
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2533050B2 (en) | Method for producing high-purity active factor VIIa concentrate | |
| EP0317376B1 (en) | Preparation of a concentrate of high-purity human factor IX and of other plasma proteins | |
| Jesty et al. | Purification of Factor VII from bovine plasma: Reaction with tissue factor and activation of Factor X | |
| Vahlquist et al. | Isolation of the human retinol binding protein by affinity chromatography | |
| US4743680A (en) | Method for purifying antihemophilic factor | |
| US5679776A (en) | Process for preparing a concentrate of blood coagulation factor VIII-von willebrand factor complex from total plasma | |
| Gentry et al. | Specific coagulation factor adsorption to insoluble heparin | |
| Vician et al. | Purification of human blood clotting factor X by blue dextran agarose affinity chromatography | |
| JP2651307B2 (en) | Complex containing blood coagulation factor IX | |
| Benson et al. | Calcium binding and other characteristics of bovine factor II and its activation intermediates | |
| US4137127A (en) | Process for the preparation of thrombin-like enzymes from snake venoms | |
| US5639857A (en) | Ultrapurification of factor IX and other vitamin k-dependent proteins | |
| US5071961A (en) | Method of enrichment of coagulation factors ii, vii, ix and x | |
| Labrou et al. | Biomimetic dye affinity chromatography for the purification of bovine heart lactate dehydrogenase | |
| NO178882B (en) | Method for Separation of Vitamin K-Dependent Blood Coagulant Factors | |
| US4675385A (en) | Isolation of human plasma procoagulant protein factor VIII from biological factors | |
| Modi et al. | The isolation of prothrombin, factor IX and factor X from human factor IX concentrates | |
| US4952675A (en) | Method for purifying antihemophilic factor | |
| US4847362A (en) | Method for purifying antihemophilic factor | |
| Velander et al. | Process implications for metal‐dependent immunoaffinity interactions | |
| WO1995011966A1 (en) | Human activated protein c preparation and process for producing the same | |
| EP0118256A2 (en) | Immunoadsorbent, and method of recovering vitamin-K dependent protein therewith | |
| Dempfle et al. | Purification of human plasma fibrinogen by chromatography on protamine-agarose | |
| Wickerhauser et al. | A Single‐Step Method for the Isolation of Antithrombin III 1, 2 | |
| US5286849A (en) | Purification of factor IX |